Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing

Megan A Allyse; David H Robinson; Matthew J Ferber; Richard R Sharp

doi:10.1016/j.mayocp.2017.11.001

Direct-to-Consumer Testing 2.0: Emerging Models of Direct-to-Consumer Genetic Testing

Mayo Clin Proc. 2018 Jan;93(1):113-120. doi: 10.1016/j.mayocp.2017.11.001.

Authors

Megan A Allyse¹, David H Robinson¹, Matthew J Ferber², Richard R Sharp³

Affiliations

¹ Center for Individualized Medicine, Mayo Clinic, Rochester, MN; Biomedical Ethics Research Program, Mayo Clinic, Rochester, MN.
² Center for Individualized Medicine, Mayo Clinic, Rochester, MN.
³ Center for Individualized Medicine, Mayo Clinic, Rochester, MN; Biomedical Ethics Research Program, Mayo Clinic, Rochester, MN. Electronic address: [email protected].

PMID: 29304915
DOI: 10.1016/j.mayocp.2017.11.001

Abstract

Direct-to-consumer (DTC) genetic testing emerged in the early 2000s as a means of allowing consumers to access information on their genetics without the involvement of a physician. Although early models of DTC were popular with consumers, they were controversial in medical and regulatory circles. In this article, we trace the history of DTC genetic testing, discuss its regulatory implications, and describe the emergence of a new hybrid model we call DTC 2.0.

Publication types

Comparative Study
Historical Article
Review

MeSH terms

Computer-Assisted Instruction / methods*
Curriculum
Direct-To-Consumer Screening and Testing / history*
Direct-To-Consumer Screening and Testing / methods*
Education, Medical, Continuing / methods*
Genetic Testing / history*
Genetic Testing / methods
History, 21st Century
Humans
Minnesota